These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 18450852
21. Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides. Ovsyannikova IG, Vierkant RA, Poland GA. Vaccine; 2006 Jun 19; 24(25):5381-9. PubMed ID: 16714073 [Abstract] [Full Text] [Related]
22. Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. Dhiman N, Poland GA, Cunningham JM, Jacobson RM, Ovsyannikova IG, Vierkant RA, Wu Y, Pankratz VS. J Allergy Clin Immunol; 2007 Sep 19; 120(3):666-72. PubMed ID: 17560639 [Abstract] [Full Text] [Related]
27. Vaccine immunogenetics: bedside to bench to population. Poland GA, Ovsyannikova IG, Jacobson RM. Vaccine; 2008 Nov 18; 26(49):6183-8. PubMed ID: 18598732 [Abstract] [Full Text] [Related]
28. Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes. Xie J, Mothe B, Alcalde Herraiz M, Li C, Xu Y, Jödicke AM, Gao Y, Wang Y, Feng S, Wei J, Chen Z, Hong S, Wu Y, Su B, Zheng X, Cohet C, Ali R, Wareham N, Alhambra DP. Nat Commun; 2024 May 13; 15(1):4031. PubMed ID: 38740772 [Abstract] [Full Text] [Related]
31. Evaluation of cellular immunity to mumps in vaccinated individuals with or without circulating antibodies up to 16 years after their last vaccination. Vandermeulen C, Clement F, Roelants M, Van Damme P, Hoppenbrouwers K, Leroux-Roels G. J Infect Dis; 2009 May 15; 199(10):1457-60. PubMed ID: 19320590 [Abstract] [Full Text] [Related]
37. Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines. Ovsyannikova IG, Dhiman N, Jacobson RM, Poland GA. Expert Rev Vaccines; 2006 Feb 15; 5(1):33-43. PubMed ID: 16451106 [Abstract] [Full Text] [Related]
38. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella. Tischer A, Gerike E. Vaccine; 2000 Jan 31; 18(14):1382-92. PubMed ID: 10618536 [Abstract] [Full Text] [Related]
39. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months. Kontio M, Palmu AA, Syrjänen RK, Lahdenkari M, Ruokokoski E, Davidkin I, Vaarala O, Melin M. J Infect Dis; 2016 Jun 15; 213(12):2005-13. PubMed ID: 26908733 [Abstract] [Full Text] [Related]